Ibetin (Ibuprofen)

Ibuprofen inhibits cyclooxygenase enzymes COX‑1 and COX‑2, which convert arachidonic acid into prostaglandins. By lowering prostaglandin synthesis, it diminishes inflammation, pain signaling, and fever generation, which underlies its analgesic, antipyretic, and anti‑inflammatory effects.

The dosage of Ibetin is determined by the prescribing healthcare professional based on the individual’s age, condition, and response. Typical adult regimens range from 200 mg to 400 mg taken every 4‑6 hours, not exceeding the maximum daily limit, but exact dosing must follow the prescriber’s instructions.

Ibuprofen is generally avoided during the third trimester of pregnancy because it may affect fetal cardiovascular function. In earlier trimesters, it should only be used if clearly needed and prescribed. While small amounts pass into breast milk, nursing mothers should consult a healthcare provider before using Ibetin.

To request Ibetin, visit the product page on gnhindia.com, submit an enquiry with the desired quantity, and provide institutional or trade credentials. GNH India’s procurement team will verify eligibility, then respond with pricing, availability, shipping options, and any required import documentation for hospitals, pharmacies, or clinics worldwide.

Ibetin (ibuprofen) shares the core NSAID mechanism of COX inhibition with drugs such as naproxen and diclofenac, but it has a relatively short half‑life, allowing flexible dosing. Compared with aspirin, ibuprofen has a lower risk of gastrointestinal irritation at standard doses, though all NSAIDs carry similar bleeding risks.

Ibetin should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and excessive heat. Keep the container tightly closed and out of reach of children. Do not refrigerate or freeze the product, as this may affect tablet integrity.

Ibetin is taken orally, usually as a tablet, with a full glass of water. It can be taken with or without food, although ingesting it with meals may reduce gastrointestinal discomfort. The tablet should be swallowed whole; it is not intended for crushing or chewing.

The most serious adverse reactions to Ibetin include gastrointestinal bleeding or ulcer perforation, severe allergic reactions such as anaphylaxis, renal impairment, and rare hepatic injury. Patients experiencing black stools, severe abdominal pain, swelling, or signs of an allergic response should seek immediate medical attention.

Ibetin should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, those with active gastrointestinal ulcers, severe renal or hepatic impairment, and in the third trimester of pregnancy. Caution is also advised for patients on anticoagulant therapy or with uncontrolled hypertension, and a healthcare professional should evaluate suitability.